Biomm develops and markets medicines, including the reusable insulin application device Biopemm for diabetic patients. The company's focus is on improving the quality of life for people with chronic diseases through biotechnology and expanding their access to high technology. Biomm's main goal is to develop, produce, and market biomedicines of global competitiveness, with a focus on quality and affordability.
Headquarters
Avenida Regent, N 705, Lote 15 Ao 21, Alphaville
Nova Lima; Minas Gerais;
Postal Code: 34018000
Contact Details: Purchase the Biomm S.A. report to view the information.
Website: http://www.biomm.com
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS service
To view more information, Request a demonstration of the EMIS service